Eduardo F. Coelho

Belo Horizonte, MG, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

Pre-clinical evaluation of (2E,5E)-2,5-bis(isoquinolin-5-ylmethylene)-cyclopentanone as a promising leishmanicidal agent.

Pre-clinical evaluation of (2E,5E)-2,5-bis(isoquinolin-5-ylmethylene)-cyclopentanone as a promising leishmanicidal agent.

Journal: Acta tropica
Published: May 19, 2026

In silico discovery and serological validation of Trypanosoma cruzi-specific B-cell epitopes for high-precision Chagas disease diagnosis.

In silico discovery and serological validation of Trypanosoma cruzi-specific B-cell epitopes for high-precision Chagas disease diagnosis.

Journal: Frontiers in microbiology
Published: April 14, 2026

Advances in the Development of Antigens for the Most Prevalent Hepatitis for Biotechnological Applications.

Advances in the Development of Antigens for the Most Prevalent Hepatitis for Biotechnological Applications.

Journal: Current medicinal chemistry
Published: January 26, 2026

Recombinant Proteins, Multiepitope Constructs, and Synthetic Peptides for ELISA-Based Diagnosis of Leptospirosis: A Comprehensive Review.

Recombinant Proteins, Multiepitope Constructs, and Synthetic Peptides for ELISA-Based Diagnosis of Leptospirosis: A Comprehensive Review.

Journal: Current medicinal chemistry
Published: January 08, 2026

A Global View on the use of Synthetic Peptides in ELISA-Based Serodiagnosis of Human Infectious Diseases.

A Global View on the use of Synthetic Peptides in ELISA-Based Serodiagnosis of Human Infectious Diseases.

Journal: Current medicinal chemistry
Published: November 05, 2025

A Biotechnological Review of Potential Patents for Serological Diagnosis of Hepatitis Delta Virus.

A Biotechnological Review of Potential Patents for Serological Diagnosis of Hepatitis Delta Virus.

Journal: Current pharmaceutical biotechnology
Published: October 22, 2025

Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection.

Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection.

Journal: Parasitology international
Published: July 02, 2025

Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb/c mice.

Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb/c mice.

Journal: Research in veterinary science
Published: April 08, 2025

Improving diagnostic accuracy in visceral leishmaniasis: Chimeric protein-based approach.

Improving diagnostic accuracy in visceral leishmaniasis: Chimeric protein-based approach.

Journal: Diagnostic microbiology and infectious disease
Published: March 05, 2025

Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D.

Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D.

Journal: Amino acids
Published: January 31, 2025

Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice.

Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice.

Journal: Frontiers in immunology
Published: December 31, 2024

Rational synthesis, activity and mechanism insights of a new aminoquinoline salt against malaria parasites: in vitro and in vivo approaches.

Rational synthesis, activity and mechanism insights of a new aminoquinoline salt against malaria parasites: in vitro and in vivo approaches.

Journal: Chemico-biological interactions
Published: August 22, 2024
Showing 1-12 of 92

Last Updated: 09/26/2026